Pfizer Made ‘Groundless Threats’ to Pharmacies in Patent Dispute
- Allergan unit wins patent clash over generic version of Lyrica
- U.K. judge chides Pfizer over messages to doctors & drugstores
Pfizer Inc. medication.
Photographer: Daniel Acker/BloombergThis article is for subscribers only.
Pfizer Inc. was accused by a U.K. judge of making “groundless threats” of legal action against British doctors and drugstores if they prescribed or sold a generic version of its best-selling Lyrica treatment.
Judge Richard Arnold issued the rebuke as he ruled that Allergan Plc’s Actavis unit didn’t infringe Pfizer patents with its version of the drug pregalbin.